INTRODUCTION AND AIMS POPULATION AND METHODS
Orthotopic liver transplantation (OLT) has become the treatment of choice for advanced liver disease of almost any cause.
Improved outcomes among solid organ transplant recipients have contributed to the growth in the absolute number of patients with chronic kidney disease (CKD) in this group, and this complication significantly compromises patients outcome 1-3 .
The aim of this study was to determine the incidence of acute and chronic 
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RESULTS
OLT recipients:
• Male gender 64%
• Mean age: 44±12.6 years Indications for transplantation • Mean follow up time 3.6 years, 29% > to 5 years
• Mean transplant survival: 75% at 12 months and 69% at 3 years
• RD pre (GFRe < 60 ml/min or Scr >1.5 mg/dl): 133 recipients (21.6%)
• Retransplanted: 82 recipients 
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CONCLUSIONS
